Świętokrzyskie Centrum Onkologii w Kielcach

What Świętokrzyskie Centrum Onkologii w Kielcach does

Świętokrzyskie Centrum Onkologii w Kielcach (ŚCO) is a government-owned public oncology hospital and Samodzielny Publiczny Zakład Opieki Zdrowotnej (independent public healthcare institution) operating as the sole comprehensive cancer center for Poland's Świętokrzyskie Voivodeship. Founded in 1991 and headquartered at ul. Stefana Artwińskiego 3 in Kielce, it provides the full oncology care continuum — prevention, diagnostics, surgery, chemotherapy, radiotherapy, immunotherapy, cellular therapy, genetic engineering, clinical trials, and rehabilitation — to the regional population, with approximately 35 listed core employees supplemented by a clinical trial research team of about 60. Its core technology stack includes a Zakład Inżynierii Genetycznej (Genetic Engineering Laboratory) that was first in Poland to produce lentiviral vectors for cell therapies, two latest-generation da Vinci robotic surgery systems, an Early Phase Trials Room and Clinical Trials Room within the Day Chemotherapy Center, and a fleet of mobile diagnostic units (Cytomammobus, Urobus, Krwiobus) delivering mammography, cytology, HPV testing, prostate ultrasound, and phlebotomy directly to municipalities and workplaces.

ŚCO's subsidiary Onkologiczne Centrum Wsparcia Badań Klinicznych (OnkoCWBK), established in 2021, coordinates 59 active Phase I-IV oncology clinical trials across 19+ indications including neuroendocrine tumors, ovarian cancer, AML, prostate cancer, multiple myeloma, lung cancer, melanoma, and CAR-T-eligible hematologic malignancies, supporting over 100 patients on modern therapies. Its business model is dual-track: (1) publicly funded healthcare delivery reimbursed by the Narodowy Fundusz Zdrowia (NFZ) under Poland's universal healthcare system, with services provided free at point of use to insured patients; and (2) substantial EU and state grant funding — cumulatively approximately PLN 135M+ across programs from the European Social Fund, Fundusze Europejskie dla Świętokrzyskiego 2021-2027, Agencja Badań Medycznych (ABM), and the Krajowy Plan Odbudowy (KPO) — covering preventive screening, oncological rehabilitation, and clinical research infrastructure expansion. The center is governed by Director Prof. Stanisław Góźdź, with Dr Jolanta Smok-Kalwat as Deputy Director for Clinical Affairs and Marta Krzysiek heading OnkoCWBK, and reports to the Marszałek Województwa Świętokrzyskiego under the regional government's administrative authority.

Name

Świętokrzyskie Centrum Onkologii w Kielcach

Legal name

Świętokrzyskie Centrum Onkologii Samodzielny Publiczny Zakład Opieki Zdrowotnej

Website

https://onkol.kielce.pl

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Świętokrzyskie Centrum Onkologii is a Polish public oncology hospital and regional clinical research center providing comprehensive cancer care — prevention, treatment, clinical trials, genetic engineering, and rehabilitation — to the Świętokrzyskie voivodeship, funded by NFZ reimbursement and EU grants.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Medical and Diagnostic Laboratories (6215), Other Ambulatory Health Care Services (6219)

SIC

Services-Hospitals (8060), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAFAHAC

Oncology & Cancer Specialty Hospitals

Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care

SECONDARYHLAFAAAM

Hospital-Integrated Cancer Centers (Acute Oncology Programs)

Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems

SECONDARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAFAG

Surgical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLALAGAH

Oncology Telemedicine Platforms

Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

• Oncology hospital services
• Clinical trials research
• Cancer prevention screening
• Cell and gene therapy
• Oncological rehabilitation

Headquarters

HQ city

Kielce

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Publicly Funded Healthcare Services (NFZ): Świętokrzyskie Centrum Onkologii is a Samodzielny Publiczny Zakład Opieki Zdrowotnej (Independent Public Healthcare Institution). It provides oncology services reimbursed by the Polish National Health Fund (Narodowy Fundusz Zdrowia, NFZ) under Poland's universal public healthcare system. Services include diagnostics, surgery, chemotherapy, radiotherapy, immunotherapy, and clinical trials.
2. EU-Funded Project Revenue: ŚCO receives substantial EU funding through multiple grant programs for preventive health projects targeting the Świętokrzyskie population. These include projects on employee prevention (PLN 94.8M from European Funds), oncological rehabilitation (PLN 21.3M), clinical research infrastructure (PLN 6.8M from Medical Research Agency), and scientific capacity building (PLN 6.0M from KPO).

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Świętokrzyskie Centrum Onkologii is a public oncology hospital providing comprehensive cancer care from prevention and screening through diagnosis, treatment (surgery including da Vinci robotic surgery, chemotherapy, radiotherapy, immunotherapy, cellular therapies), and oncological rehabilitation. It also operates a dedicated Clinical Trial Support Center (OnkoCWBK) running Phase I-IV oncology trials, a Genetic Engineering Laboratory producing lentiviral vectors for cell therapies, and a fleet of mobile diagnostic units (Cytomammobus, Urobus, Krwiobus) that bring screening services to communities across the Świętokrzyskie Voivodeship.

Product overview

Świętokrzyskie Centrum Onkologii is a public oncology hospital providing comprehensive cancer treatment and prevention services. The facility operates as a multi-product healthcare organization consisting of the main oncology hospital, the Onkologiczne Centrum Wsparcia Badań Klinicznych (OnkoCWBK) coordinating clinical trials phases I-IV, mobile diagnostic units (Cytomammobus, Urobus, Krwiobus), specialized clinical facilities (Early Phase Trials Room, Clinical Trials Room, Sponsor Meetings Center), and preventive health programs (Biała Sobota screening events, Profilaktyka Świętokrzyskich Pracowników, rehabilitation programs). The center also includes a Genetic Engineering Laboratory producing lentiviral vectors for cell therapies, and an e-Platform for decentralized clinical trials. Key infrastructure includes robotic surgical capabilities with da Vinci systems.

Differentiator

Problem solved

Functional benefit

Brands

• Cytomammobus: Mobile diagnostic unit for mammography and cervical cytology examinations serving the Świętokrzyskie region
• Krwiobus
• Urobus
• Cytobus

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Uzdrowisko Busko-Zdrój S.A.coreStrategic or Co-development Partner · 1 July 2025Partnership in the 21.3M PLN oncological rehabilitation project targeting 2,000 working oncological patients. Uzdrowisko Busko-Zdrój provides 10-day rehabilitation stays (600 participants) including physical therapy, psychological support, and recreational activities in a spa setting, while ŚCO delivers individual rehabilitation programs and coordinates participant referrals.
• Wojewódzki Ośrodek Medycyny Pracy w Kielcach (WOMP)coreStrategic or Co-development Partner · 1 July 2024WOMP is the lead partner in the 94.8M PLN 'Prevention of Świętokrzyskie Employees' project (FESW.07.01). ŚCO serves as the implementing partner providing clinical services including laboratory tests, specialist consultations, mobile diagnostics, and genetic testing. Project targets 55,000 working residents aged 40+ across the entire Świętokrzyskie region.
• Świętokrzyski Klub Amazonki (Breast Cancer Survivors Support Group)minorStrategic or Co-development PartnerPartner in breast cancer screening projects (2021-2023), providing patient education, self-examination training on phantoms, and peer support during screening events. Amazonki members participate in Białe Soboty and community events.
• Stowarzyszenie na rzecz walki z rakiem jajnika Niebieski Motyl (Blue Butterfly Ovarian Cancer Association)minorStrategic or Co-development PartnerPartner in cervical cancer prevention project for the southern subregion of Świętokrzyskie, collaborating on patient outreach and educational activities.
• Samodziałowy Zakład Podstawowej Opieki Zdrowotnej w ChęcinachminorStrategic or Co-development PartnerLocal primary care partner in the northern subregion breast cancer screening project, supporting patient referrals and community outreach in the Chęciny area.
• Gminny Zakład Opieki Zdrowotnej w KrasocinieminorStrategic or Co-development PartnerLocal primary care partner in the southern subregion cervical cancer prevention project, providing POZ consultations and patient referral support.
• Akademia Medycznych i Społecznych Nauk Stosowanych w ElbląguminorStrategic or Co-development PartnerEducational institution sending Clinical Research and Biobanking students for study visits to OnkoCWBK ŚCO, enabling practical training on clinical trial operations and fostering future workforce development in clinical research.
• Fundacja Pokonaj Raka (Conquer Cancer Foundation)minorStrategic or Co-development PartnerCo-organizer of the V Health Picnic (Piknik Zdrowia) together with ŚCO, bringing together over 250 participants and 500+ consultations with health education and free screenings.
• Świętokrzyski Oddział Wojewódzki NFZ (National Health Fund)minorStrategic or Co-development PartnerRegional branch of Poland's public health insurer, collaborating on preventive health education events such as Pink October and providing information about national screening programs at community health events.
• Regionalny Ośrodek Polityki Społecznej Urzędu Marszałkowskiego Województwa ŚwiętokrzyskiegominorStrategic or Co-development PartnerRegional social policy body organizing senior wellness events (Senior w plenerze) in collaboration with ŚCO, promoting oncology prevention and clinical trial awareness among seniors in the Kielce area.

Scale indicators12 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Gustave Roussy Institute: Leading European comprehensive cancer center in France combining treatment, research and prevention at large scale. Comparable for integrating clinical trials, advanced therapies and public-health-oriented oncology programs, but operates at national/international scale rather than voivodeship level.
• Karolinska University Hospital (Oncology Section): Large Swedish academic hospital with a comprehensive oncology program including Phase I trials, cell therapy, and advanced radiotherapy. Comparable for translational oncology research infrastructure and clinical trial scale, but as a broader academic medical center rather than a regional specialty hospital.

Regional players

• Klinika Onkologii i Hematologii Dziecięcej "Przylądek Nadziei": Pediatric oncology and hematology clinic at University Clinical Hospital in Wrocław. Comparable for clinical trial infrastructure and oncology research capability, though pediatric-focused and operating in a different geography.

Direct peers

• Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii: Multi-specialty oncology, pulmonology and hematology center in Wrocław serving Lower Silesia. Comparable as another large regional Polish oncology center with research infrastructure and clinical trial operations.
• Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli: Public oncology hospital in Lublin providing comprehensive cancer diagnostics, treatment and clinical research for eastern Poland. Comparable as another voivodeship-level oncology specialty hospital with similar NFZ-funded operating model.
• Centrum Onkologii i Instytut im. Marii Skłodowskiej-Curie (Gliwice branch): Heavy-ion radiotherapy and oncology research branch of Poland's national oncology institute, recognized for advanced radiopharmaceutical therapy. Comparable for cutting-edge oncology technology and clinical trial capability at national level.
• Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie: Poland's flagship national oncology research institute and hospital in Warsaw, providing comprehensive oncology care and a large Phase I-IV clinical trial portfolio. Closest peer given similar mission of integrated treatment, research and prevention, though at materially larger national scale.
• Wielkopolskie Centrum Onkologii: Regional oncology center in Poznań serving the Wielkopolskie voivodeship with comparable mix of inpatient oncology, radiotherapy, surgery and clinical trials. Most direct structural peer given similar voivodeship-level public hospital status and full-service oncology scope.

Others

• European Cancer Organisation (ECO) member network: Not-for-profit umbrella representing European oncology professionals and institutions; relevant as ecosystem context for ŚCO's clinical trial partnerships and pan-European sponsor engagement rather than as a direct comparator.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCGzZp4KdhCZRZT4qgFF8DDA
• Facebookfacebook.com/scokielce
• LinkedInlinkedin.com/company/%C5%9Bwi%C4%99tokrzyskie-centrum-onkologii-w-kielcach

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Świętokrzyskie Centrum Onkologii w Kielcach